STOCK TITAN

Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Zomedica Corp. CEO, Larry Heaton, to participate in fireside chat and one-on-one meetings with investors at Lytham Partners 2024 Investor Select Conference. The webcasted fireside chat will take place at 10:15am ET on Thursday, February 1, 2024, and can be accessed on the Company's website or directly at a provided link.
Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners 2024 Investor Select Conference, taking place virtually on February 1st, 2024.

The Company's webcasted fireside chat will take place at 10:15am ET on Thursday, February 1, 2024. The webcast can be accessed on the Company's website at https://investors.zomedica.com/ or directly at https://wsw.com/webcast/lytham10/zom/1948896. The webcast will also be archived and available for replay.

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit https://www.zomedica.com.

Follow Zomedica
Email Alerts: http://investors.zomedica.com

LinkedIn: https://www.linkedin.com/company/zomedica

Facebook: https://m.facebook.com/zomedica

Twitter: https://twitter.com/zomedica

Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

Investor Contacts
Lytham Partners, LLC
Robert Blum
1-602-889-9700

SOURCE: Zomedica Corp.



View the original press release on accesswire.com

FAQ

When will the webcasted fireside chat take place?

The webcasted fireside chat will take place at 10:15am ET on Thursday, February 1, 2024.

Where can the webcast be accessed?

The webcast can be accessed on the Company's website at https://investors.zomedica.com/ or directly at https://wsw.com/webcast/lytham10/zom/1948896.

Will the webcast be available for replay?

Yes, the webcast will be archived and available for replay.

What is the ticker symbol for Zomedica Corp.?

The ticker symbol for Zomedica Corp. is ZOM.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

142.29M
963.34M
1.59%
8.89%
6.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ANN ARBOR

About ZOM

zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.